Yunqian Pan
- Cancer Research top 5%
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 11
- Epigenetics and DNA Methylation 7
- Protein Degradation and Inhibitors 7
- Cancer-related gene regulation 7
- PI3K/AKT/mTOR signaling in cancer 5
- RNA modifications and cancer 5
- FOXO transcription factor regulation 5
- Oncology top 5%
-
- Prostate Cancer Treatment and Research 16
Yunqian Pan
40 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 559
- Molecular Biology 1.6k
- Oncology 457
- Pulmonary and Respiratory Medicine 491
- Aging 17
Countries citing papers authored by Yunqian Pan
This map shows the geographic impact of Yunqian Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunqian Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunqian Pan more than expected).
Fields of papers citing papers by Yunqian Pan
This network shows the impact of papers produced by Yunqian Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunqian Pan. The network helps show where Yunqian Pan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yunqian Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2023 | 23 | |
| 3 | 2021 | 54 | |
| 4 | 2021 | 25 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 31 | |
| 7 | 2019 | 60 | |
| 8 | 2019 | 14 | |
| 9 | 2019 | 17 | |
| 10 | 2018 | 51 | |
| 11 | 2017 | 77 | |
| 12 | 2017 | 50 | |
| 13 | 2017 | 47 | |
| 14 | 2014 | 35 | |
| 15 | 2014 | 80 | |
| 16 | 2014 | 59 | |
| 17 | Chemopreventive agents modulate the protein expression profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J mice | 2007 | 6 |
| 18 | 2004 | 40 | |
| 19 | The cyclooxygenase 2-specific nonsteroidal anti-inflammatory drugs celecoxib and nimesulide inhibit androgen receptor activity via induction of c-Jun in prostate cancer cells. | 2003 | 37 |
| 20 | 2001 | 155 |
About Yunqian Pan
Yunqian Pan is a scholar working on Cancer Research, Aging and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 2.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (16 papers), Ubiquitin and proteasome pathways (11 papers), Epigenetics and DNA Methylation (7 papers), Protein Degradation and Inhibitors (7 papers), Cancer-related gene regulation (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), RNA modifications and cancer (5 papers) and FOXO transcription factor regulation (5 papers). The work is most often cited by research in Cancer Research (559 citations), Molecular Biology (1.6k citations) and Oncology (457 citations). Yunqian Pan has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Haojie Huang, Liguo Wang, Xin Jin, Yuqian Yan, Laura R. Bohrer, Donald J. Tindall, R. Jeffrey Karnes, John C. Cheville, Yundong He and Jingting Jiang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.